Table 2. Arterial blood gas and laboratory test results.
ALT: Alanine aminotransferase; AST: aspartate aminotransferase; DB: direct bilirubin; BNP: B-type natriuretic peptide; TB: total bilirubin; ERS: erythrocyte sedimentation rate; ALP: alkaline phosphatase; FiO2: fraction of inspired oxygen; GamaGT: gamma-glutamyl transferase; LDH: lactate dehydrogenase; MCHC: mean corpuscular hemoglobin concentration; MCV: mean corpuscular volume; pCO2: partial pressure of carbon dioxide; pO2: partial pressure of oxygen
| Days of hospitalization | 74 | 80 | 84 | 109 | |
| Significant events | D36 of linezolid | Three days after linezolid suspension | Seven days after linezolid suspension | Seven days after starting daptomycin | |
| Arterial blood gas | FiO2 | 24% | 21% | ||
| pH | 7.41 | 7.48 | |||
| pO2 | 87 mmHg | 70 mmHg | |||
| pCO2 | 44 mmHg | 54 mmHg | |||
| Oxygen saturation | 98% | 95% | |||
| HCO3- | 27.9 mmol/L | 36.6 mmol/L | |||
| Lactate | 7.3 mmol/L | 0.6 mmol/L | |||
| Ca2+ | 1.16 mmol/L | 1.16 mmol/L | |||
| Complete blood count, biochemistry | Hemoglobin | 9.2 g/dL | 8.3 g/dL | 8.1 g/dL | 10.5 g/dL |
| MCV | 90.0 fL | 87.2 fL | 90.4 fL | 91.8 fL | |
| MCHC | 32.1 g/dL | 33.1 g/dL | 32.9 g/dL | 32.4 g/dL | |
| Leukocytes | 4.57x109/L | 6.35x109/L | 7.14x109/L | 8.08 x109/L | |
| Neutrophilis | 90% | 73% | 73% | 75% | |
| Platelets | 173x109/L | 139x109/L | 243x109/L | 386 x109/L | |
| ERS | 45 mm | ||||
| Glucose | 181 mg/dL | 150 mg/dL | 127 mg/dL | 170 mg/dL | |
| Urea | 29.0 mg/dL | 35.0 mg/dL | 33.0 mg/dL | 28.0 mg/dL | |
| Creatinine | 0.55 mg/dL | 0.46 mg/dL | 0.47 mg/dL | 0.45 mg/dL | |
| Na+ | 134 mmol/L | 134 mmol/L | 139 mmol/L | 138 mmol/L | |
| K+ | 4.1 mmol/L | 4.6 mmol/L | 4.1 mmol/L | 5.1 mmol/L | |
| TB/DB, ALP, GamaGT, AST/ALT | No alterations | ||||
| LDH | 185 UI/L | 254 UI/L | 179 UI/L | ||
| C-reactive protein | 2.24 mg/dL | 4.85 mg/dL | 16.03 mg/dL | 5.93 mg/dL | |
| Myoglobin, troponin I, BNP | No alterations | ||||
| Urinalysis | No alterations | ||||